Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anterix (ATEX) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Anterix (ATEX) over the last 12 years, with Q4 2025 value amounting to -$3.7 million.

  • Anterix's Change in Accured Expenses fell 29281.25% to -$3.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$1.4 million, marking a year-over-year decrease of 29466.48%. This contributed to the annual value of $550000.0 for FY2025, which is 7159.09% down from last year.
  • According to the latest figures from Q4 2025, Anterix's Change in Accured Expenses is -$3.7 million, which was down 29281.25% from $4.7 million recorded in Q3 2025.
  • Over the past 5 years, Anterix's Change in Accured Expenses peaked at $4.7 million during Q3 2025, and registered a low of -$3.7 million during Q4 2025.
  • In the last 5 years, Anterix's Change in Accured Expenses had a median value of $39500.0 in 2023 and averaged $3800.0.
  • In the last 5 years, Anterix's Change in Accured Expenses plummeted by 87258.06% in 2021 and then skyrocketed by 2212857.14% in 2025.
  • Over the past 5 years, Anterix's Change in Accured Expenses (Quarter) stood at $2.1 million in 2021, then crashed by 44.05% to $1.2 million in 2022, then rose by 3.32% to $1.2 million in 2023, then surged by 58.15% to $1.9 million in 2024, then tumbled by 292.81% to -$3.7 million in 2025.
  • Its Change in Accured Expenses stands at -$3.7 million for Q4 2025, versus $4.7 million for Q3 2025 and -$2.6 million for Q2 2025.